Cellebrite Ownership

CLBT Stock  USD 20.18  1.18  6.21%   
Cellebrite holds a total of 214.84 Million outstanding shares. Over half of Cellebrite's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Cellebrite in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Cellebrite, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
At this time, Cellebrite's Dividend Yield is comparatively stable compared to the past year. Dividend Payout Ratio is likely to gain to 1.32 in 2024, whereas Dividends Paid is likely to drop 0.00 in 2024. Net Income Applicable To Common Shares is likely to gain to about 145.9 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 188.7 M in 2024.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cellebrite DI. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Cellebrite Stock Ownership Analysis

About 47.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.58. Cellebrite DI had not issued any dividends in recent years. Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Cellebrite Mobile Synchronization Ltd. operates as a subsidiary of Sun Corporation. Cellebrite operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. It employs 900 people. For more info on Cellebrite DI please contact Yossi Carmil at 972 73 394 8000 or go to https://www.cellebrite.com.
Besides selling stocks to institutional investors, Cellebrite also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Cellebrite's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Cellebrite's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Cellebrite Quarterly Liabilities And Stockholders Equity

629.25 Million

About 47.0% of Cellebrite DI are currently held by insiders. Unlike Cellebrite's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Cellebrite's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Cellebrite's insider trades

Cellebrite Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Cellebrite is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cellebrite DI backward and forwards among themselves. Cellebrite's institutional investor refers to the entity that pools money to purchase Cellebrite's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Pembroke Management Ltd2024-09-30
1.9 M
Ashford Capital Management Inc2024-06-30
1.9 M
Blackrock Inc2024-06-30
1.9 M
Crescent Park Management, L.p.2024-09-30
1.7 M
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Ltd2024-09-30
1.5 M
Renaissance Technologies Corp2024-09-30
1.5 M
Principal Financial Group Inc2024-09-30
1.4 M
Two Sigma Investments Llc2024-06-30
1.4 M
Goldman Sachs Group Inc2024-06-30
1.3 M
Morgan Stanley - Brokerage Accounts2024-06-30
14 M
True Wind Capital Management, L.p.2024-09-30
11.7 M
Note, although Cellebrite's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Cellebrite Outstanding Bonds

Cellebrite issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cellebrite DI uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cellebrite bonds can be classified according to their maturity, which is the date when Cellebrite DI has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Cellebrite Corporate Filings

6K
6th of November 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
F3
17th of September 2024
An amendment to the original Schedule 13D filing
ViewVerify
12th of April 2024
Other Reports
ViewVerify
21st of March 2024
Other Reports
ViewVerify

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cellebrite Stock Analysis

When running Cellebrite's price analysis, check to measure Cellebrite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellebrite is operating at the current time. Most of Cellebrite's value examination focuses on studying past and present price action to predict the probability of Cellebrite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellebrite's price. Additionally, you may evaluate how the addition of Cellebrite to your portfolios can decrease your overall portfolio volatility.